NCR1 and neoplasm: HSC‐engrafted NSG‐Tg(Hu‐IL15) mice that were treated with the NKp46 depleting antibody showed increased tumor growth kinetics as compared to isotype treated HSC‐engrafted NSG‐Tg(Hu‐IL15) mice (Figure 8B).